Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2024)

Almac Group
Almac Group, an established CDMO, provides a unique range of integrated drug development services to the pharmaceutical and biotech industry. Our quality, innovation and efficiency are why over 600 companies worldwide trust Almac to support their clinical trials and ultimately commercialisation. Our...
View profile

Featured Speaker (BOS Basel 2024)

Outsourcing of API and Formulation Manufacturing of a Compound with Segregation Needs.

Dr Yogeshwar Bachhav, Director (Consultant), AiCuris Anti-infective Cures AG

ABSTRACT: Investigations compound with segregation needs present a significant challenge in outsourcing the drug substance and drug product production. A handful of CDMOs are available across the globe that can manage these compounds' production, significantly impacting drug development timelines and budgets. In his presentation at BOS Basel 2024, Dr Yogeshwar Bachhav (Director, Consultant) at AiCuris Anti-infective Cures AG, Germany, will highlight the obstacles to outsourcing DS and DP manufacturing for a compound needing segregation while handling Click here to Read More